RESUMO
Dicephalic parapagus tribrachius conjoined twin is a very rare condition. We present a case of 5-days-old male dicephalic parapagus conjoined twins. The conjoined twins were diagnosed in 4[th] month of pregnancy by ultrasonography. The pregnancy terminates at 36 weeks by cesarean section and triplets were born. The babies were male conjoined twins and another healthy male baby. Many congenital defects of interest can now be detected before birth. Sever form of this malformation precludes postpartum life. It is supposed that with advances in screening methods for prenatal diagnosis these cases are terminated in first or second trimester of pregnancy
RESUMO
The purpose of this study was to compare the mortality and morbidity rates of neonatal respiratory distress syndrome [RDS] treated with and without surfactant in ventilated patients. In this descriptive-analytical study, the morbidity and mortality rates of RDS in 50 patients of the study group treated with surfactant were compared with 66 patients of control group treated without surfactant. The children of the control group received treatment at a time when surfactant was not available in market. Surfactant was used as Survanta during the first 24 hours of life with a dose of 4 ml/kg in four different positions through tracheal tube only once. The two groups were comparable in baseline parameters including birth weight, sex, gestational age and primary diagnosis. Mortality reduced significantly. There were no differences in the incidence of severe complications including, intraventricular hemorrhage and patent ductus arteriosus, but pneumothorax, sepsis and pulmonary hemorrhage occurred more common in the control group. Use of surfactant in neonatal respiratory distress syndrome significantly decreased mortality, pneumothorax, sepsis and pulmonary hemorrhage